Igene Biotechnology

(OTC) IGNE

Current Price$0.00

Market Cap$1.60K

Since IPO (1990)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Igene Biotechnology Financials at a Glance

Market Cap

$1.60K

Revenue (TTM)

$4.80K

Net Income (TTM)

-$2.37M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4.68 (High)

Dividend

$0.00

Beta (Volatility)

4.68 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

4.68 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

IGNE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Igene Biotechnology

Industry

Chemicals

Sector

Materials

Headquarters

Columbia, MD 21045, US

IGNE Financials

Key Financial Metrics (TTM)

Gross Margin

25.66%

Operating Margin

-27.03%

Net Income Margin

-3.56%

Return on Equity

5.19%

Return on Capital

-26.39%

Return on Assets

-2.96%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.60K

Shares Outstanding

1.57B

Volume

Avg. Volume

33.93K

Financials (TTM)

Gross Profit

$40.85K

Operating Income

-$2.33M

EBITDA

-$457.78K

Operating Cash Flow

-$1.68M

Capital Expenditure

$16.62K

Free Cash Flow

-$1.67M

Cash & ST Invst.

$269.29K

Total Debt

$7.34M

Igene Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2010YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.60K

N/A

Market Cap/Employee

$88.89

N/A

Employees

N/A

Net Income

-$627.24K

-646.3%

EBITDA

-$57.76K

-109.4%

Quarterly Fundamentals

Name

Q3 2010YOY CHG

Total Cash

$269.29K

-89.7%

Total Debt

$7.34M

-0.4%

Accounts Receivable

$2.17M

+16.7%

Inventory

$0.00

N/A

Long Term Debt

$5.72M

+0.7%

Short Term Debt

$1.61M

-4.1%

Return on Assets

-2.96%

N/A

Return on Invested Capital

-33.43%

N/A

Free Cash Flow

-$710.59K

-3.0%

Operating Cash Flow

-$710.59K

-3.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLSDFSelect Sands Corp.

SLSDFSelect Sands Corp.$0.00+0.00%

GRENGreensmart Corp

GRENGreensmart Corp$0.00+0.00%

CBLRFCampbell Resources Inc.

CBLRFCampbell Resources Inc.$0.00+0.00%

VRCVVarca Ventures, Inc.

VRCVVarca Ventures, Inc.$0.00+0.00%

AGYPAllied Energy Corp.

AGYPAllied Energy Corp.$0.00+0.00%

XMTTFXmet Inc.

XMTTFXmet Inc.$0.00+0.00%

PRMOProm Resources, Inc.

PRMOProm Resources, Inc.$0.05-2.62%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$16.14+0.00%

NOKNokia

NOKNokia$13.70-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.44-0.10%

PFEPfizer

PFEPfizer$24.72-0.01%

TAT&T

TAT&T$22.81+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.56+0.10%

FFord Motor Company

FFord Motor Company$14.00-0.01%

Questions About IGNE

What is the current price of Igene Biotechnology?

Igene Biotechnology is trading at $0.00 per share.

What is the 52-week range for Igene Biotechnology?

Over the past 52 weeks, Igene Biotechnology has traded between $0.00 and $0.00.

How much debt does Igene Biotechnology have?

Igene Biotechnology total debt is unavailable.

How much cash does Igene Biotechnology have on hand?

Igene Biotechnology does not have cash on hand data available.

What is Igene Biotechnology’s dividend yield?

Igene Biotechnology does not currently have a dividend yield.

Igene Biotechnology

Igene Biotechnology Financials at a Glance

IGNE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Igene Biotechnology

IGNE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Igene Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IGNE

What is the current price of Igene Biotechnology?

What is the 52-week range for Igene Biotechnology?

How much debt does Igene Biotechnology have?

How much cash does Igene Biotechnology have on hand?

What is Igene Biotechnology’s dividend yield?

Premium Investing Services